Pain, fatigue, depression, and anxiety are common in the year after MS diagnosisMay 28, 2019Multiple Sclerosis
Fingolimod reduced disease activity more than glatiramer acetate in RRMS: ASSESS study resultsMay 14, 2019Multiple Sclerosis
